BJDX Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States...

Stats
Dagens volum	571 313
Gjennomsnittsvolum	48 417.00
Markedsverdi	1.73M
EPS	$0 ( 2024-03-25 )
Neste inntjeningsdato	( $-0.720 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0700
ATR14	$0.0150 (2.34%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-13	Dey Svetlana	Buy	500	Common Stock
2023-12-13	Dey Indranil	Buy	500	Common Stock
2023-09-26	Scally Frances P	Buy	0
2023-03-24	Dey Svetlana	Buy	10 000	Common Stock
2023-03-28	Dey Indranil	Buy	2 000	Common Stock

INSIDER POWER
43.51
Last 55 transactions
Buy: 889 772 \| Sell: 456 992

Bluejay Diagnostics, Inc. Korrelasjon

10 Mest positive korrelasjoner
BPYPP	0.971
ISTR	0.97
ADES	0.968
SFBS	0.968
FFWM	0.966
SGMO	0.965
NUWE	0.965
FSEA	0.964
ARVL	0.964
IMBI	0.962

10 Mest negative korrelasjoner
MSDA	-0.972
BRIVU	-0.97
VLAT	-0.964
ADAL	-0.962
TIOAU	-0.961
TIOA	-0.96
PPYAU	-0.956
ZING	-0.956
NVCN	-0.953
BRIV	-0.952

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Bluejay Diagnostics, Inc. Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-780 955 (0.00 %)
EPS:	$-9.08

FY	2023
Omsetning:	$0
Bruttogevinst:	$-780 955 (0.00 %)
EPS:	$-9.08

FY	2022
Omsetning:	$249 040
Bruttogevinst:	$48 911.00 (19.64 %)
EPS:	$-9.15

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.275

Financial Reports:

No articles found.

Bluejay Diagnostics, Inc.

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.